In New Suit, Illumina Alleges Affy's GeneTitan System, Associated Products Infringe its IP

The new litigation commenced nearly a year and a half after Illumina paid Affy a one-time $90 million payment to settle multiple suits without admitting liability.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.